Women's Health News RSS Feed - Women's Health News

Lancet study highlights long-term effect of 1999 nationwide strategy to reduce teenage pregnancy

Lancet study highlights long-term effect of 1999 nationwide strategy to reduce teenage pregnancy

Rates of teenage pregnancy in England have halved since the implementation of the Government's Teenage Pregnancy Strategy (TPS) in 1999, and the greatest effect is seen in areas of high deprivation and areas that received the most TPS funding, according to research published in The Lancet. [More]
Early epigenetic changes could open way for new preventative strategies for ovarian cancer

Early epigenetic changes could open way for new preventative strategies for ovarian cancer

Research revealing early changes at epigenetic level points to possible new prevention strategies for ovarian cancer. The discovery of early changes in the cells of the Fallopian tubes of women carrying the BRCA genetic mutation could open the way for new preventative strategies for ovarian cancer, reducing the need for invasive surgery, according to research published today in science journal Nature Communications. [More]
Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Telephone-based intervention helps reduce menopause-related insomnia, hot flashes

Chatting on the phone with a "sleep coach" and keeping a nightly sleep diary significantly improve sleep quality and reduce insomnia in women through all stages of menopause, according to a new study published today in JAMA Internal Medicine. [More]
Vitamin D and androgen receptor-targeted therapy may help treat TNBC

Vitamin D and androgen receptor-targeted therapy may help treat TNBC

A recent study by researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine revealed that triple-negative breast cancer (TNBC), which has generally been unresponsive to hormone receptor-targeted treatments, can indeed be treated using vitamin D and androgen receptor-targeted therapy. [More]
BUSM researchers uncover genetic, epigenetic alteration overlaps in breast and ovarian cancer

BUSM researchers uncover genetic, epigenetic alteration overlaps in breast and ovarian cancer

While breast cancer is the most common cause of cancer death in women worldwide, ovarian cancer also is a significant source of mortality as the fifth leading cause of cancer death among women. [More]
Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

Chemical compound eCF506 may be highly effective at blocking growth of breast cancer cells

A drug for breast cancer that is more effective than existing medicines may be a step closer thanks to new research. [More]
Women's group lobbies lawmakers to fund Illinois Breast and Cervical Cancer Program

Women's group lobbies lawmakers to fund Illinois Breast and Cervical Cancer Program

On May 12th, the Metropolitan Chicago Breast Cancer Task Force traveled to Springfield, Illinois to lobby lawmakers to fully fund the Illinois Breast and Cervical Cancer Program, which provides free mammograms and Pap testing for uninsured women aged 35 to 64. [More]
Study highlights need for support services to address reproductive concerns of female cancer survivors

Study highlights need for support services to address reproductive concerns of female cancer survivors

A new study indicates that many young adult female cancer survivors do not receive adequate information about their fertility as part of their survivorship care after completing treatment, despite having concerns about their ability to bear children in the future. [More]
Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

Investigational drug abemaciclib shows durable clinical activity for variety of cancer types

The investigational anticancer therapeutic abemaciclib, which targets CDK4 and CDK6, showed durable clinical activity when given as continuous single-agent therapy to patients with a variety of cancer types, including breast cancer, non-small cell lung cancer (NSCLC), glioblastoma, and melanoma, according to results from a phase I clinical trial. [More]
New real-time imaging technique holds great potential in shaping assisted reproduction procedures

New real-time imaging technique holds great potential in shaping assisted reproduction procedures

Researchers at A*STAR's Institute of Molecular and Cell Biology (IMCB) have developed advanced microscopy technologies to monitor embryo development in real time, revealing how mammalian cells differentiate during the earliest stages of embryonic life. [More]
Study shows young adult female cancer survivors do not receive adequate information about their fertility

Study shows young adult female cancer survivors do not receive adequate information about their fertility

A new study indicates that many young adult female cancer survivors do not receive adequate information about their fertility as part of their survivorship care after completing treatment, despite having concerns about their ability to bear children in the future. [More]
Rural, low-income mothers face obstacles in accessing outdoor recreation resources

Rural, low-income mothers face obstacles in accessing outdoor recreation resources

Research shows that spending just 20 minutes in nature can promote health and well-being. Although the assumption may be that living in rural areas provides ample opportunities for recreation in nature, many rural, low-income mothers, who rely on outdoor activities to promote health and well-being for themselves and their families, face obstacles in accessing publicly available outdoor recreation resources. [More]
Combination of chemotherapy and immunotherapy may be effective against ovarian cancer

Combination of chemotherapy and immunotherapy may be effective against ovarian cancer

Inside each ovarian tumor, there are good cells and bad cells: The bad cells are fibroblasts. They work to block chemotherapy, which is why nearly every woman with ovarian cancer becomes resistant to treatment. [More]
DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

DECT trial shows combination of epirubicin and trastuzumab improves outcomes in breast cancer patients

The study entitled "A phase II neoadjuvant sequential regimen of docetaxel followed by high-dose epirubicin in combination with cyclophosphamide administered concurrently with trastuzumab. [More]
New research looks at conversations that take place among selected parenting groups on Facebook

New research looks at conversations that take place among selected parenting groups on Facebook

A study of conversations among pregnant women and new mothers on Facebook has highlighted a need for health professionals to provide clear direction on where new parents and pregnant women can access reliable and evidence based information about medicines. [More]
New BMS survey highlights overlooked needs of women experiencing menopause

New BMS survey highlights overlooked needs of women experiencing menopause

A new survey conducted by Ipsos MORI on behalf of the British Menopause Society has revealed that one in two women in Great Britain go through the menopause without consulting a healthcare professional. [More]
EAD therapy can shrink size of triple-negative breast cancer tumors in mice

EAD therapy can shrink size of triple-negative breast cancer tumors in mice

In a new study using mice and lab-grown human cells, a scientific team led by Johns Hopkins Kimmel Cancer Center researchers show how a triple-drug cocktail can shrink triple-negative breast cancers by killing off cancer cells and halting new tumor growth. [More]
Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Study examines effects of ultra-low doses of glyphosate on gene expression profiles

Glyphosate, often sold under the brand name of Roundup, is the world's most widely used weed-killer. While Glyphosate has approval from regulatory bodies worldwide, there are growing concerns about its possible adverse health effects. [More]
Researchers identify low MCJ expression as marker of poor response to chemotherapy

Researchers identify low MCJ expression as marker of poor response to chemotherapy

Chemotherapy is a key part of the standard treatment regimen for triple-negative breast cancer patients whose cancer lacks expression of estrogen and progesterone receptors and the human epidermal growth factor receptor 2 (HER2). [More]
Loss of HOXA5 protein may allow breast cancer cells to thrive

Loss of HOXA5 protein may allow breast cancer cells to thrive

Many breast cancers are marked by a lack of HOXA5 protein, a gene product known to control cell differentiation and death, and lower levels of the protein correspond to poorer outcomes for patients. [More]
Advertisement
Advertisement